# Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications

> **NCT00158834** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 200 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Salmeterol/Fluticasone propionate combination product
- **DRUG:** Fluticasone propionate

## Key facts

- **NCT ID:** NCT00158834
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 200 (—)
- **Last updated:** 2008-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00158834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00158834, "Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00158834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*